Home » Topics » BioWorld Science

BioWorld Science
RSS

OAT1 mediates nociceptive sensitization and is a target for treating pain

March 10, 2022

Targeting iASPP-TMCO1 axis may represent a promising therapeutic target in cancer

March 9, 2022

NIH grant supports cholera research at Illinois Institute of Technology

March 9, 2022

Funding for Psilera's evaluation of novel DMT derivatives for mood and addiction disorders

March 9, 2022

ESMO TAT: Heating cold tumors one subtype, and one cell type, at a time

March 9, 2022

Ghost mitochondria drive tumor progression through EIF2AK4/Akt signaling

March 9, 2022

ATH-1020, a novel HGF/MET positive modulator with promising preclinical efficacy

March 9, 2022

BAL-0891 shows potent single agent activity in mouse model of TNBC

March 9, 2022

New lipid nanoparticles allow mRNA delivery to the lung for treating lymphangioleiomyomatosis

March 9, 2022

Zinc oxide nanoparticles target integrin alpha-v beta-3 for breast cancer treatment

March 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...